Moreover, the up-regulation of S100A9 aggravates LPS-induced acute lung injury by activating macrophage M1 polarization and pyroptosis via the TLR4/MyD88/NF-κB pathway, which suggests a potential key target for AP therapy [5]. Here, S100A9 is linked to alkaline phosphatase measurement.